Matches in SemOpenAlex for { <https://semopenalex.org/work/W2332434333> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W2332434333 endingPage "A48" @default.
- W2332434333 startingPage "A48.1" @default.
- W2332434333 abstract "<h3>Introduction</h3> Transcatheter aortic valve implantation (TAVI) is associated with peri and post-procedural morbidity and mortality. Currently there is a lack of an established scoring system to further stratify patients who are potential TAVI candidates. We used the CHA<sub>2</sub>DS<sub>2</sub>-Vasc score and a modified R<sub>2</sub>CHADS-VASC score that we devised, (R2- for pre-existing Renal impairment, and pre-existing Rhythm abnormality (RBBB/LBBB) on ECG to determine if they predict mortality and morbidity in patients undergoing TAVI. <h3>Methods</h3> The data source is a retrospective analysis of prospective data registry of consecutive patients who underwent TAVI at two tertiary centres between April 2008 and April 2013. <h3>Results</h3> A total of 236 patients with severe aortic stenosis underwent TAVI. 215 patients received the CoreValve(®) (Medtronic Inc., Minneapolis, USA) prosthesis while 21 had Edwards-SAPIEN (Edward Lifesciences, Irvine, California) prosthesis.Mean age was 80 ± 8 years. Patients demographics included: 44% (103) female, 25% (59) diabetic, 67%(157) hypertensive, 44% (66), 60% (136) smokers and 27% (42) had chronic renal failure. 18 (12%) had previous transient ischaemic attacks or cerebrovascular accident. The 28-day mortality was 19.2% in those patients with a CHA<sub>2</sub>DS<sub>2</sub>-Vasc score of ≥6 whereas only 5.6% in those with a score <6 (p < 0.05). Using the R<sub>2</sub>-CHA<sub>2</sub>DS<sub>2</sub>-Vasc score, the difference was more pronounced with a 28-day mortality of 25% in those patients with a R<sub>2</sub>- CHA<sub>2</sub>DS<sub>2</sub>-Vasc score of ≥7 compared to 5.8% in those with a R<sub>2</sub>- CHA<sub>2</sub>DS<sub>2</sub>-Vasc of <7 (p < 0.05). The 1yr mortality rates, however, were not statistically significantly associated with the CHA<sub>2</sub>DS<sub>2</sub>-Vasc or R<sub>2</sub>- CHA<sub>2</sub>DS<sub>2</sub>-Vasc scores. <h3>Conclusion</h3> Our study demonstrates the potential use of the CHA<sub>2</sub>DS<sub>2</sub>-Vasc Score and the modified R2-CHA<sub>2</sub>DS<sub>2</sub>-Vasc scores to risk stratify patients undergoing the TAVI procedure." @default.
- W2332434333 created "2016-06-24" @default.
- W2332434333 creator A5006043313 @default.
- W2332434333 creator A5012614640 @default.
- W2332434333 creator A5022868259 @default.
- W2332434333 creator A5067244524 @default.
- W2332434333 creator A5074248949 @default.
- W2332434333 creator A5078304440 @default.
- W2332434333 date "2014-05-31" @default.
- W2332434333 modified "2023-10-18" @default.
- W2332434333 title "82 Does the CHA2S2VASC or R2-CHA2DS2VASC Predict Procedural and Short-term Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation" @default.
- W2332434333 doi "https://doi.org/10.1136/heartjnl-2014-306118.82" @default.
- W2332434333 hasPublicationYear "2014" @default.
- W2332434333 type Work @default.
- W2332434333 sameAs 2332434333 @default.
- W2332434333 citedByCount "0" @default.
- W2332434333 crossrefType "journal-article" @default.
- W2332434333 hasAuthorship W2332434333A5006043313 @default.
- W2332434333 hasAuthorship W2332434333A5012614640 @default.
- W2332434333 hasAuthorship W2332434333A5022868259 @default.
- W2332434333 hasAuthorship W2332434333A5067244524 @default.
- W2332434333 hasAuthorship W2332434333A5074248949 @default.
- W2332434333 hasAuthorship W2332434333A5078304440 @default.
- W2332434333 hasConcept C126322002 @default.
- W2332434333 hasConcept C141071460 @default.
- W2332434333 hasConcept C144024400 @default.
- W2332434333 hasConcept C149923435 @default.
- W2332434333 hasConcept C164705383 @default.
- W2332434333 hasConcept C167135981 @default.
- W2332434333 hasConcept C2776570981 @default.
- W2332434333 hasConcept C2778715743 @default.
- W2332434333 hasConcept C2780007028 @default.
- W2332434333 hasConcept C2780084366 @default.
- W2332434333 hasConcept C2781414266 @default.
- W2332434333 hasConcept C71924100 @default.
- W2332434333 hasConceptScore W2332434333C126322002 @default.
- W2332434333 hasConceptScore W2332434333C141071460 @default.
- W2332434333 hasConceptScore W2332434333C144024400 @default.
- W2332434333 hasConceptScore W2332434333C149923435 @default.
- W2332434333 hasConceptScore W2332434333C164705383 @default.
- W2332434333 hasConceptScore W2332434333C167135981 @default.
- W2332434333 hasConceptScore W2332434333C2776570981 @default.
- W2332434333 hasConceptScore W2332434333C2778715743 @default.
- W2332434333 hasConceptScore W2332434333C2780007028 @default.
- W2332434333 hasConceptScore W2332434333C2780084366 @default.
- W2332434333 hasConceptScore W2332434333C2781414266 @default.
- W2332434333 hasConceptScore W2332434333C71924100 @default.
- W2332434333 hasIssue "Suppl 3" @default.
- W2332434333 hasLocation W23324343331 @default.
- W2332434333 hasOpenAccess W2332434333 @default.
- W2332434333 hasPrimaryLocation W23324343331 @default.
- W2332434333 hasRelatedWork W1881873954 @default.
- W2332434333 hasRelatedWork W1973893055 @default.
- W2332434333 hasRelatedWork W2062431605 @default.
- W2332434333 hasRelatedWork W2127773604 @default.
- W2332434333 hasRelatedWork W2145397396 @default.
- W2332434333 hasRelatedWork W2433597602 @default.
- W2332434333 hasRelatedWork W2548731293 @default.
- W2332434333 hasRelatedWork W2595809140 @default.
- W2332434333 hasRelatedWork W2793221628 @default.
- W2332434333 hasRelatedWork W2804618992 @default.
- W2332434333 hasVolume "100" @default.
- W2332434333 isParatext "false" @default.
- W2332434333 isRetracted "false" @default.
- W2332434333 magId "2332434333" @default.
- W2332434333 workType "article" @default.